Canada Markets open in 3 hrs 27 mins

AREV Life Sciences Global Corp. (AREVF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2000+0.0097 (+5.11%)
At close: 01:06PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.1903
BidN/A x N/A
AskN/A x N/A
Day's Range0.1800 - 0.2000
52 Week Range0.0655 - 0.3752
Avg. Volume7,622
Market Cap5.566M
Beta (5Y Monthly)2.30
PE Ratio (TTM)N/A
EPS (TTM)-0.0660
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB

    REVISED RELEASE first issued July 28, 2021 VANCOUVER, British Columbia, Sept. 07, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) announces that the Company has entered into a collaborative development agreement with Voynich Biosciences, Inc. (“Voynich”) that further advances AREV’s flagship initiative, the next-generation Ready-to-Use Therapeutic Food (“RUTF”), SUS-TAINN™. Voynich is an early-stage, privately-held, phytomedicinal discovery co

  • GlobeNewswire

    AREV Announces Brian Cameron as Chief Financial Officer

    VANCOUVER, British Columbia, Sept. 02, 2021 (GLOBE NEWSWIRE) -- AREV LIFE SCIENCES GLOBAL CORP. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce Brian Cameron as Chief Financial Officer (“CFO”), effective September 2, 2021. Mr. Cameron has owned and operated a corporate finance consultancy, Cameron & Associates, since 1983, with offices in Vancouver Canada, Seattle Washington and Phoenix, Arizona. Prior to forming Cameron & Associates, Mr. Cameron was employed by Price W

  • GlobeNewswire

    Data Presented at the 11th IAS Conference on HIV Science Supports AREV’s Development of SUS-TAINN™, a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation

    VANCOUVER, British Columbia , July 22, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce the Company’s RUTF product development premise has been validated. Recent data presented this week on the co-intersection of HIV and nutrition at the 11th International AIDS Society Conference on HIV Science (IAS 2021), held virtually with a hub in Berlin, demonstrates the need for innovation in the universal address of famine, starvat